Related Experiment Video
Updated: Feb 1, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Relationship Between the Severity of Coronary Artery Disease and Renal Function
Metin Karayakali1, Hasan Kadi2, Kayıhan Karaman1
1Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey.
Insights
Estimated glomerular filtration rate (eGFR) is linked to coronary atherosclerosis. Declining eGFR significantly increases the risk of severe coronary artery disease, underscoring the importance of kidney function in cardiovascular health.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Estimated glomerular filtration rate (eGFR) is a recognized component of cardiovascular risk assessment.
- The anatomical basis of this risk, specifically coronary atherosclerotic burden, is not well-characterized across the spectrum of renal function.
Purpose of the Study:
- To investigate the association between eGFR and coronary atherosclerotic burden.
- To provide anatomical validation for the inclusion of eGFR in cardiovascular risk prediction models.
Main Methods:
- Retrospective analysis of 1181 patients undergoing elective coronary angiography.
- Patients stratified into groups based on eGFR levels (≥90, 60-89, and 30-59 mL/min/1.73 m²).
- Coronary atherosclerotic burden quantified using the Gensini score.
Main Results:
- A significant inverse correlation was observed between eGFR and Gensini score (ρ = -0.352, P < .001).
- Each 10 mL/min/1.73 m² decline in eGFR was associated with a 40% increased odds of severe coronary atherosclerosis (OR = 0.960, P < .001).
- Patients with eGFR 30-59 mL/min/1.73 m² had a 6-fold higher odds of severe coronary atherosclerosis compared to those with preserved renal function (OR = 6.073, P < .001), independent of traditional risk factors.
Conclusions:
- The study provides angiographic evidence linking reduced eGFR to increased coronary atherosclerotic burden.
- Even mild renal dysfunction is associated with a higher atherosclerotic burden, reinforcing the cardiovascular-kidney-metabolic health continuum.
- Findings support aggressive cardiovascular risk modification strategies in patients with declining renal function, especially diabetic women.
Abstract:
The American Heart Association's Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations established estimated glomerular filtration rate (eGFR) as a component of cardiovascular risk assessment. However, the anatomical substrate underlying this risk-coronary atherosclerotic burden-remains inadequately characterized across renal function spectrum. This retrospective study included 1181 patients (mean age: 60.2 ± 8.9 years, 65.7% male) undergoing elective coronary angiography. Patients divided groups using eGFR; eGFR ≥90 (n = 596), 60 to 89 (n = 497), and 30 to 59 mL/min/1.73 m2 (n = 88) were evaluated by stratification. Coronary atherosclerotic burden was determined using Gensini score. eGFR demonstrated a strong correlation with Gensini score (ρ = -0.352, P < .001). Each 10 mL/min/1.73 m2 eGFR decline conferred 40% increased odds of severe coronary atherosclerosis (odds ratio [OR] = 0.960, 95% CI: 0.951-0.970, P < .001). Patients with eGFR 30 to 59 mL/min/1.73 m2 exhibited 6-fold higher odds compared with preserved renal function (OR 6.073, 95% CI: 3.352-11.005, P < .001), independent of traditional risk factors. This study provides an anatomical validation for incorporating eGFR into cardiovascular risk assessment. Our angiographic evidence demonstrates that even mild renal dysfunction is accompanied by increased atherosclerotic burden. These findings bridge the gap between epidemiological risk prediction and pathophysiological reality, reinforcing the cardiovascular-kidney-metabolic health continuum and supporting aggressive risk modification strategies in patients with declining renal function, particularly among diabetic women.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction

